Edmund Lee

Company: Regulus Therapeutics

Job title: Executive Director, Biology

Seminars:

Inhibition of miR-17 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) 9:30 am

Investigating preclinical data supporting miR-17 as therapeutic target for ADPKD Assessing translational research leading up to the development of clinically-relevant urinary biomarker for ADPKD Exploring clinical data demonstrating target engagement and proof of mechanism in ADPKD patientsRead more

day: Day Two